Nutraceutical Excipients Market Size At Around US$ 6.9 Bn In 2030

The nutraceutical excipients market would grow at a CAGR of 6.98% over the predicted time frame. The market is expected to increase in value from US$ 4.02 Bn in 2022 to US$ 6.98 Bn in 2030.

The on nutraceutical excipients Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.

Download Free Sample@ https://www.precedenceresearch.com/sample/1912

Report Scope of the Nutraceutical Excipients Market

Report Coverage	Details
Market Size in 2022	USD 4.02 Billion
Market Size by 2030	USD 6.9 Billion
Growth Rate from 2022 to 2030	CAGR of 6.98%
Base Year	2021
Forecast Period	2022 to 2030
Segments Covered	Functionality, Product, Type, Form, End Use, Geography

A recent report provides crucial insights along with application based and forecast information in the Global Nutraceutical excipients Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Nutraceutical excipients market.

A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.

Companies and Manufacturers Covered

The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Nutraceutical excipients market are included as given below:

Nutraceutical excipients Market Key Players

• DuPont
• BASF SE
• Cargill Inc
• Shin-Etsu Chemical Co Ltd
• Associated British Foods
• Roquette Freres
• Meggle Group Wasser
• Kerry Group PLC
• Fuji Chemical Industries Co Ltd
• PharmatransSanaq AG
• Pioma Chemicals
• Gattefosse
• Ingredion Plc
• Sensient Technologies
• W.R. Grace & Co
• Omya
• Grain Processing Corp

Market Segments

By Functionality

• Binder
  • MCC
  • HPMC
  • HPC
• Disintegrants
  • Crosspovidone
  • Croscarmellose
• Fillers & Diluents
• Coating Agent
• Flavoring Agent
• Lubricants
• Others

By Product

• Prebiotics
• Probiotics
• Proteins & Amino Acids

By Type

• Artificial
• Natural/Organic

By Form

• Dry
• Liquid

By End Use

• Protein and Amino Acids
• Omega 3 Fatty Acids
• Vitamins
• Minerals
• Prebiotics and Probiotics
• Others

By Geography

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • France
• Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Malaysia
  • Philippines
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC
  • North Africa
  • South Africa
  • Rest of the Middle East & Africa

Report Objectives

• To define, describe, and forecast the global nutraceutical excipients market based on product, and region
• To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
• To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
• To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
• To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
• To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the nutraceutical excipients market

Table of Content

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Nutraceutical Excipients Market 

5.1. COVID-19 Landscape: Nutraceutical Excipients Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Nutraceutical Excipients Market, By Functionality

8.1. Nutraceutical Excipients Market, by Functionality, 2022-2030

8.1.1. Binder

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Disintegrants

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Fillers & Diluents

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Coating Agent

8.1.4.1. Market Revenue and Forecast (2017-2030)

8.1.5. Flavoring Agent

8.1.5.1. Market Revenue and Forecast (2017-2030)

8.1.6. Lubricants

8.1.6.1. Market Revenue and Forecast (2017-2030)

8.1.7. Others

8.1.7.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Nutraceutical Excipients Market, By Product

9.1. Nutraceutical Excipients Market, by Product, 2022-2030

9.1.1. Prebiotics

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Probiotics

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Proteins & Amino Acids

9.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Nutraceutical Excipients Market, By Type 

10.1. Nutraceutical Excipients Market, by Type, 2022-2030

10.1.1. Artificial

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Natural/Organic

10.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Nutraceutical Excipients Market, By Form

11.1. Nutraceutical Excipients Market, by Form, 2022-2030

11.1.1. Dry

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Liquid

11.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Nutraceutical Excipients Market, By End Use

12.1. Nutraceutical Excipients Market, by End Use, 2022-2030

12.1.1. Protein and Amino Acids

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. Omega 3 Fatty Acids

12.1.2.1. Market Revenue and Forecast (2017-2030)

12.1.3. Vitamins

12.1.3.1. Market Revenue and Forecast (2017-2030)

12.1.4. Minerals

12.1.4.1. Market Revenue and Forecast (2017-2030)

12.1.5. Prebiotics and Probiotics

12.1.5.1. Market Revenue and Forecast (2017-2030)

12.1.6. Others

12.1.6.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global Nutraceutical Excipients Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Functionality (2017-2030)

13.1.2. Market Revenue and Forecast, by Product (2017-2030)

13.1.3. Market Revenue and Forecast, by Type (2017-2030)

13.1.4. Market Revenue and Forecast, by Form (2017-2030)

13.1.5. Market Revenue and Forecast, by End Use (2017-2030)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Functionality (2017-2030)

13.1.6.2. Market Revenue and Forecast, by Product (2017-2030)

13.1.6.3. Market Revenue and Forecast, by Type (2017-2030)

13.1.6.4. Market Revenue and Forecast, by Form (2017-2030)

13.1.7. Market Revenue and Forecast, by End Use (2017-2030) 

13.1.8. Rest of North America

13.1.8.1. Market Revenue and Forecast, by Functionality (2017-2030)

13.1.8.2. Market Revenue and Forecast, by Product (2017-2030)

13.1.8.3. Market Revenue and Forecast, by Type (2017-2030)

13.1.8.4. Market Revenue and Forecast, by Form (2017-2030)

13.1.8.5. Market Revenue and Forecast, by End Use (2017-2030)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Functionality (2017-2030)

13.2.2. Market Revenue and Forecast, by Product (2017-2030)

13.2.3. Market Revenue and Forecast, by Type (2017-2030)

13.2.4. Market Revenue and Forecast, by Form (2017-2030) 

13.2.5. Market Revenue and Forecast, by End Use (2017-2030) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Functionality (2017-2030)

13.2.6.2. Market Revenue and Forecast, by Product (2017-2030)

13.2.6.3. Market Revenue and Forecast, by Type (2017-2030)

13.2.7. Market Revenue and Forecast, by Form (2017-2030) 

13.2.8. Market Revenue and Forecast, by End Use (2017-2030) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Functionality (2017-2030)

13.2.9.2. Market Revenue and Forecast, by Product (2017-2030)

13.2.9.3. Market Revenue and Forecast, by Type (2017-2030)

13.2.10. Market Revenue and Forecast, by Form (2017-2030)

13.2.11. Market Revenue and Forecast, by End Use (2017-2030)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Functionality (2017-2030)

13.2.12.2. Market Revenue and Forecast, by Product (2017-2030)

13.2.12.3. Market Revenue and Forecast, by Type (2017-2030)

13.2.12.4. Market Revenue and Forecast, by Form (2017-2030)

13.2.13. Market Revenue and Forecast, by End Use (2017-2030)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Functionality (2017-2030)

13.2.14.2. Market Revenue and Forecast, by Product (2017-2030)

13.2.14.3. Market Revenue and Forecast, by Type (2017-2030)

13.2.14.4. Market Revenue and Forecast, by Form (2017-2030)

13.2.15. Market Revenue and Forecast, by End Use (2017-2030)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Functionality (2017-2030)

13.3.2. Market Revenue and Forecast, by Product (2017-2030)

13.3.3. Market Revenue and Forecast, by Type (2017-2030)

13.3.4. Market Revenue and Forecast, by Form (2017-2030)

13.3.5. Market Revenue and Forecast, by End Use (2017-2030)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Functionality (2017-2030)

13.3.6.2. Market Revenue and Forecast, by Product (2017-2030)

13.3.6.3. Market Revenue and Forecast, by Type (2017-2030)

13.3.6.4. Market Revenue and Forecast, by Form (2017-2030)

13.3.7. Market Revenue and Forecast, by End Use (2017-2030)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Functionality (2017-2030)

13.3.8.2. Market Revenue and Forecast, by Product (2017-2030)

13.3.8.3. Market Revenue and Forecast, by Type (2017-2030)

13.3.8.4. Market Revenue and Forecast, by Form (2017-2030)

13.3.9. Market Revenue and Forecast, by End Use (2017-2030)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Functionality (2017-2030)

13.3.10.2. Market Revenue and Forecast, by Product (2017-2030)

13.3.10.3. Market Revenue and Forecast, by Type (2017-2030)

13.3.10.4. Market Revenue and Forecast, by Form (2017-2030)

13.3.10.5. Market Revenue and Forecast, by End Use (2017-2030)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Functionality (2017-2030)

13.3.11.2. Market Revenue and Forecast, by Product (2017-2030)

13.3.11.3. Market Revenue and Forecast, by Type (2017-2030)

13.3.11.4. Market Revenue and Forecast, by Form (2017-2030)

13.3.11.5. Market Revenue and Forecast, by End Use (2017-2030)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Functionality (2017-2030)

13.4.2. Market Revenue and Forecast, by Product (2017-2030)

13.4.3. Market Revenue and Forecast, by Type (2017-2030)

13.4.4. Market Revenue and Forecast, by Form (2017-2030)

13.4.5. Market Revenue and Forecast, by End Use (2017-2030)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Functionality (2017-2030)

13.4.6.2. Market Revenue and Forecast, by Product (2017-2030)

13.4.6.3. Market Revenue and Forecast, by Type (2017-2030)

13.4.6.4. Market Revenue and Forecast, by Form (2017-2030)

13.4.7. Market Revenue and Forecast, by End Use (2017-2030)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Functionality (2017-2030)

13.4.8.2. Market Revenue and Forecast, by Product (2017-2030)

13.4.8.3. Market Revenue and Forecast, by Type (2017-2030)

13.4.8.4. Market Revenue and Forecast, by Form (2017-2030)

13.4.9. Market Revenue and Forecast, by End Use (2017-2030)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Functionality (2017-2030)

13.4.10.2. Market Revenue and Forecast, by Product (2017-2030)

13.4.10.3. Market Revenue and Forecast, by Type (2017-2030)

13.4.10.4. Market Revenue and Forecast, by Form (2017-2030)

13.4.10.5. Market Revenue and Forecast, by End Use (2017-2030)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Functionality (2017-2030)

13.4.11.2. Market Revenue and Forecast, by Product (2017-2030)

13.4.11.3. Market Revenue and Forecast, by Type (2017-2030)

13.4.11.4. Market Revenue and Forecast, by Form (2017-2030)

13.4.11.5. Market Revenue and Forecast, by End Use (2017-2030)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Functionality (2017-2030)

13.5.2. Market Revenue and Forecast, by Product (2017-2030)

13.5.3. Market Revenue and Forecast, by Type (2017-2030)

13.5.4. Market Revenue and Forecast, by Form (2017-2030)

13.5.5. Market Revenue and Forecast, by End Use (2017-2030)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Functionality (2017-2030)

13.5.6.2. Market Revenue and Forecast, by Product (2017-2030)

13.5.6.3. Market Revenue and Forecast, by Type (2017-2030)

13.5.6.4. Market Revenue and Forecast, by Form (2017-2030)

13.5.7. Market Revenue and Forecast, by End Use (2017-2030)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Functionality (2017-2030)

13.5.8.2. Market Revenue and Forecast, by Product (2017-2030)

13.5.8.3. Market Revenue and Forecast, by Type (2017-2030)

13.5.8.4. Market Revenue and Forecast, by Form (2017-2030)

13.5.8.5. Market Revenue and Forecast, by End Use (2017-2030)

Chapter 14. Company Profiles

14.1. DuPont14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. BASF SE

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Cargill Inc

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Shin-Etsu Chemical Co Ltd

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Associated British Foods

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Roquette Freres

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Meggle Group Wasser

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Kerry Group PLC

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Fuji Chemical Industries Co Ltd

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. PharmatransSanaq AG

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com